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Herring oil intake results in increased levels  
of omega-3 fatty acids in erythrocytes in an urban 
population in the Czech Republic
Barbora Stankova1, Eva Tvrzicka1, Hana Bayerova2, Andreas C. Bryhn3, Morten Bryhn4
A b s t r a c t
Introduction: The prevalence of cardiovascular diseases is relatively high 
in Central European countries, which may be caused by unhealthy dietary 
habits and cigarette smoking. The traditional Czech diet is low in seafood 
– a food reported to offer some reduction of risk for myocardial infarct and 
stroke. The European Health Authority recommends regular intake of fish 
or food supplements providing at least 250 mg of the omega-3 fatty acids 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) daily. 
Material and methods: The present study included 100 subjects from Prague 
not eating fish. They were given herring fish oil capsules providing aproximate-
ly the recommended dose of EPA + DHA for 6 months. Omega-3 and other fatty 
acids were analysed from red blood cells (RBC) before and after study comple-
tion. Study parameters were omega-3 index, EPA + DHA, and the atherogenic 
index comprising saturated fatty acids divided by unsaturated fatty acids. 
Results: Mean omega-3 index at study entry was 5.1% (p < 0.01) increasing 
to 10.7%, while mean EPA + DHA increased by 112% (p < 0.01). 
Conclusions: Capsules of herring oil containing 250  mg EPA + DHA daily 
increased RBC content of omega-3 fatty acids, increasing the omega-3 index 
to low or intermediate risk values in 83% of the subjects studied. In popu-
lations with low access to or no tradition of eating fish, herring oil capsules 
providing the EU recommended dose of omega-3 fatty acids might reduce 
cardiovascular risk as indicated by the surrogate parameter omega-3 index.
Key words: fish oil, Atlantic herring, eicosapentaenoic acid, 
docosahexaenoic acid, omega-3 index, inflammatory index, atherogenic 
index.
Introduction
Cardiovascular morbidity is relatively high in Central European coun-
tries. Risk factors such as cigarette smoking, hypertension, diabetes, and 
total cholesterol elevation are common among both sexes in the Czech 
Republic [1]. Intake of seafood, fruit and vegetables is low compared to 
many other European Union member countries. The traditional Czech 
diet is mainly based on pork meat, potatoes, flour dumplings and bread. 
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Seafood is expensive and not easily accessible. It 
is quite common not to eat fish at all.
A large number of epidemiological studies have 
demonstrated the cardio-protective effect of reg-
ular intake of fish. On the other hand, interven-
tion studies using products containing the marine 
omega-3 polyunsaturated fatty acids eicosapen-
taenoic acid (EPA; 20 : 5 n-3) and docosahexaeno-
ic acid (DHA; 22 : 6 n-3) have shown conflicting re-
sults [2–9]. However, recent data from controlled 
trials conclude that EPA/DHA may be associated 
with reducing risk of cardiovascular disease, with 
a greater benefit observed among higher-risk pop-
ulations [10].
Analysis of the EPA/DHA concentration in red 
blood cells’ (RBC) phospholipid membranes is 
a method to establish seafood intake over time 
more accurately compared with food frequency 
questionnaires [11]. In comparison with plasma 
analyses, RBC have the strongest association 
with cardiac tissue omega-3 fatty acid concen-
trations, and therefore analysis of EPA/DHA in 
RBC is currently the most promising method for 
cardiovascular disease risk evaluation [12]. The 
omega-3 index relates the concentration of EPA/
DHA to the total content of 24 other fatty acids 
in the RBC phospholipid membrane [13]. A pop-
ulation of non-or low seafood eaters is reported 
to have an average omega-3 index around 4% 
[14–16]. Values ≥ 8% indicate optimal risk pre-
vention of cardiovascular disease [11]. Omega-3 
supplementation has demonstrated a significant 
increase of the omega-3 index in placebo-con-
trolled trials [17]. Due to the lack of fish in the 
diet, and a high intake of saturated fatty acids, it 
is expected that the omega-3 index values could 
be low in the Czech Republic, indicating high car-
diovascular risk.
The objective of the present study was to es-
tablish actual omega-3 index values in a  typical 
urban Czech population and to reveal whether 
this index could be increased by administration of 
fish oil capsules for 6 months providing the daily 
dose of 400 mg EPA/DHA, as recommended by EU 
Health Authorities [18]. The intention was to in-
clude a diverse sample of individuals with regard 
to age distribution. The participants were healthy 
individuals or patients present with risk factors 
for cardiovascular disease. The fish oil used was 
from the Atlantic herring species (Clupea haren-
gus) caught in the North Atlantic. The oil, mainly 
in the form of triacylglycerol, is low in environmen-
tal pollutants and heavy metals, containing about 
20% of omega-3 fatty acids combined with 50% 
mono-unsaturated fatty acids. The most common 
fish oil used for food supplements is anchovy oil, 
which is higher in omega-3 fatty acids compared 
to herring oil: EPA 20.5% and DHA 13% (values 
taken from the commercial product EPAX3000TG, 
Pelagia AS). Regarding monounsaturated fatty ac-
ids, herring oil contains almost 23% cetoleic acid 
(C 22 : 1 n-11) compared to less than 2% in ancho-
vy oil. The content of the other monounsaturat-
ed fatty acid oleic acid (C 18 : 1 n-9) is about the 
same in both oils (Table I). 
This combination of omega-3 and monoun-
saturated fatty acids is known to have beneficial 
health effects as being the common fatty acids of 
the Mediterranean diet. 
One of the beneficial effects of omega-3 fatty 
acids in the prevention of cardiovascular disease 
probably reflects amelioration of vascular inflam-
mation [19]. The secondary objective of this study 
was to characterize the effect of the omega-3 in-
tervention on the RBC content of fatty acids with 
known pro-atherogenic potential, such as palmitic 
acid (C16 : 0), namely in the context of the whole 
fatty acid composition of RBC phospholipids.
Material and methods
Subjects
One hundred individuals having low (less than 
two fish meals per month) or no intake of seafood, 
taking neither fish oil capsules nor cod liver oil, 
were recruited from an average adult population in 
Prague, Czech Republic. The subjects were healthy 
clinic personnel and their relatives and friends and 
about the same number of outpatients followed 
up in the clinic (Mediam, Prague) for uncomplicat-
ed arterial hypertension and type 2 diabetes mel-
Table I. Fatty acid composition of the herring oil 
capsules in percent
FA/ID FA % Abbreviations
C 14 : 0 7.20
C 16 : 0 14.40
C 18 : 1 n-9 10.3
C 18 : 2 n-6 1.9
C 18 : 3 n-3 1.2 ALA
C 18 : 4 n-3 3.2 STA
C 20 : 1 n-9 12.3
C 20 : 4 n-6 0.3
C 20 : 4 n-3 0.5
C 20 : 5 n-3 7 EPA
C 22 : 1 n-11 22.8
C 22 : 5 n-3 0.7 DPA
C 22 : 6 n-3 7.5 DHA
ALA – α-linolenic acid, STA – stearidonic acid, EPA – eicosapentaenoic 
acid, DPA – docosapentaenoic acid, DHA – docosahexaenoic acid.
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litus. Participants were given written information 
about the study in Czech language containing in-
formation about possible adverse effects and ben-
efits as well as their right to withdraw from the 
study at any time should they want to. The study 
was conducted in accordance with the principles 
of the Declaration of Helsinki (2008 revision) and 
with approval from the local Ethical Committee.
During the first visit the individuals were 
asked to give their written consent to participate 
in the study, and fill in a 1-month diet-recall form 
containing questions regarding intake of seafood 
products as well as cod liver oil and fish oil sup-
plements. Individuals having more than two fish 
meals per month were not included in the study. 
Subjects on anti-coagulation medication such as 
warfarin and dabigatran were excluded from the 
study due to possible bleeding complications. 
Anti-platelet therapies such as aspirin were al-
lowed. Each month the physicians contacted 
the participants by phone asking for adverse 
experiences and checking that the participants 
were taking the capsules as instructed. The par-
ticipants were asked to contact the responsible 
physician should an adverse effect occur. After 
inclusion in the study two blood specimens were 
drawn and the same procedure was repeated at 
the visit 6 months later. 
Study medication
The participants were given two 1 g capsules 
of OceanSilver herring oil every morning together 
with breakfast. Each capsule contained 200 mg of 
EPA/DHA; fatty acid composition of the herring oil 
is shown in Table I. The capsules were not to be 
taken on an empty stomach because this could 
reduce effective uptake of EPA/DHA and increase 
the risk of eructation. Each participant was given 
boxes containing the total number of capsules 
to be taken during the study period of 6 months 
(about 360 capsules). The boxes were labelled 
“fish oil capsules”, the name of the responsible 
physician along with the participant’s initials and 
a consecutive number identifying the participant. 
They were told to store the boxes at room tem-
perature. 
Blood sampling and storage  
Venous blood was collected into two 10-ml 
Vacutainer tubes with K.2.EDTA spray. Erythro-
cytes were separated from plasma by centrifuga-
tion at 2000 g at 4°C for 10 min. The plasma was 
removed and an equal volume of acid-citrate-dex-
trose solution was added to the packed cells. 
Subsequently, the aliquots of erythrocytes were 
stored at –80°C. Analyses for fatty acids were per-
formed within 1 week.
Fatty acid extraction and analysis
Erythrocytes were thawed and washed 3 times 
with ice-cold isotonic saline to remove the buffy 
coat. The packed cells were lysed with 30 ml of 
cold distilled water and centrifuged at 20 000g at 
10°C for 20 min to form a tight pellet. Supernatant 
was removed, and the above procedure was re-
peated 2 times or until the supernatant was clear. 
Then, 0.3 ml of the suspension was mixed with 
0.7 ml of 0.9% saline and lipids were extracted 
from the erythrocyte membranes by the method 
of Folch et al. [20] using dichloromethane instead 
of chloroform [21]. 
Samples were transmethylated to FAME with 
1  M sodium methoxide in dry methanol under 
a  nitrogen atmosphere in darkness, for 60 min 
at ambient temperature. The reaction mixture 
was then neutralized with 1 M acetic acid. Meth-
yl esters were extracted into hexane and passed 
through a column (5 × 20 mm) of anhydrous sodi-
um sulphate. Extracts were dried under nitrogen, 
dissolved in an appropriate volume of isooctane 
and stored at –80°C until analysed. Gas chroma-
tography was performed with a Trace GC gas chro-
matograph combined with an AS 2000 autosam-
pler (Thermo Finnigan, USA). The chromatograph 
was equipped with a capillary split/splitless injec-
tor and flame ionization detector (FID).
Analyses of FAME were performed on a fused- 
silica capillary column coated with 0.25 μm 
chemically bonded stationary phase Select 
FAME (100 m, 0.25 mm I.D., Agilent Technolo-
gies, The Netherlands). The oven temperature 
was programmed from 80°C to 120°C at 4°/
min, to 270°C at 2°/min, then isothermal for 
25 min. The injector and detector temperatures 
were 250 and 270°C, respectively. Hydrogen car-
rier gas was maintained at a  head pressure of 
70 kPa and split flow 10 ml/min, splitless time 
0.25 min. Integration software Clarity (Data Apex 
Ltd. Prague, Czech Rep.) was used for data ac-
quisition and handling. Fatty acid methyl esters 
from 12 : 0 to 24 : 1n9 were separated, identified 
and expressed as percent of total. 
Data collection
Patient data were collected in Case Report 
Forms. Sex, age, weight and length were recorded. 
Body mass index (BMI) was computed. 
Statistical analysis
All of the analysed variables showed high re-
semblance to normal distribution curves. Conse-
quently, standard t-tests were performed in Mic-
rosoft Excel to compare results before and after 
treatment. The 95% confidence level was used 
to indicate statistical significance, and p-values 
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were provided for each t-test. In addition, mean 
values and standard errors of the mean were cal-
culated to be displayed in the bar chart figures 
below.
Results
Experimental cohort
One hundred subjects were included in the 
study. One left for permanent stay abroad and was 
registered as a  dropout but inclusion data were 
used for calculation of the omega-3 index. Of the 
other 99 subjects, 61 were female and 38 male. 
Adverse effects were uncommon and reported 
in only four subjects complaining of eructations. 
A change from morning to evening dosing solved 
the problems and no one was lost to follow-up 
due to adverse effects. 
Age distribution is given in Figure 1 and BMI 
distribution is shown in Figure 2.
Omega-3 index
The mean omega-3 index at study inclusion 
in 100 subjects was 6.6 % with maximum value 
45.1% and minimum value 0.3 %. Omega-3 in-
dex values in humans seldom exceed 15%. Val-
ues around 20% have been reported in dolphins 
feeding on fish only [22]. We have no explana-
tion for the extreme values exceeding 20% in 
four subjects with no intake of seafood (re-anal-
ysis of the samples revealed reproducibility of 
the results; not shown). The 4 subjects were 
excluded as outliers and not included in the fi-
nal evaluation. Finally the study included 95 
people having a  mean omega-3 index at study 
inclusion of 5.1%. The omega-3 distribution of 
the population including 95 subjects is shown 
in Figure 3. After the 6-month intervention, the 
mean omega-3 index had increased to 10.7%. 
The difference between means is statistically 
significant (p < 0.01), Figure 4. Fifty-seven of the 
participants (60%) reached an omega-3 index 
≥ 8%, considered as an optimal value regarding 
cardiovascular risk, while 22 (23%) had an index 
between 5 and 8, indicating “intermediate car-
diovascular risk” [13].
Regarding the absolute contents of fatty acids, 
the mean EPA + DHA concentration was 0.50 μg/
ml at inclusion (max: 1.88 and min: 0.03) and it 
increased to 1.06 μg/ml (max: 3.66 and min: 0.07) 
in response to the intervention. The difference 
between means was statistically significant (p < 
0.01) (Figure 5). The individual omega-3 fatty ac-
ids increased to the same extent with mean EPA 
from 0.13 to 0.27 μg/ml and mean DHA from 0.37 
to 0.78 μg/ml.
Cumulative number of the study subjects
Figure 1. Age distribution of the 100 study subjects
A
ge
 [y
ea
rs
]
90
80
70
60
50
40
30
20
10
0
Cumulative number of the study subjects
Figure 2. Body mass index distribution of the  
100 study subjects
BM
I [
kg
/m
2 ]
50
45
40
35
30
25
20
15
10
5
0
Cumulative number of the study subjects
Figure 3. Omega-3 index at study inclusion in  
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The omega-3 index is influenced as much by de-
nominator fatty acids such as saturated fatty acids 
and mono-unsaturated fatty acids as by nominator 
fatty acids EPA + DHA. Mean sum of saturated fat-
ty acids was 51.16 μg/ml at inclusion (max: 63.20, 
min: 40.12) and at study end 45.84 μg/ml (max: 
61.45, min: 35). The difference did not reach statis-
tical significance. Among the fatty acids the level of 
palmitic acid (C16:0) was 27.66 μg/ml at inclusion 
(max: 38.81, min: 20.47) and decreased to 24 μg/
ml (max: 30.14, min: 18.38) at study end (p < 0.05). 
Other saturated fatty acids were not significantly re-
duced. Therefore, a C16 : 0 reduction in the denom-
inator did add to the increased omega-3 index after 
6 months of treatment.
Atherogenic index
The atherogenic index reflects an increased 
risk of developing myocardial infarction or stroke 
in the face of high intake of saturated fatty acids. 
In this index,  saturated fatty acids C12 : 0, C14 : 0, 
and C16 : 0 are in the nominator and the poly-
unsaturated omega-3 and omega-6 fatty acids to-
gether with the mono-unsaturated fatty acids are 
in the denominator [23]. A high atherogenic index 
would transfer into risk of atherosclerotic diseas-
es. The atherogenic index was reduced from 2.27 
to 1.17 in response to the intervention (Figure 6), 
a  difference not reaching statistical significance. 
Only a small reduction in monounsaturated fatty 
acids was recorded (mean 33.64 μg/ml before and 
30.99 μg/ml at study end). 
In summary, our data strongly indicate that the 
increase in omega-3 index and the reduction of 
the atherogenic index in response to the interven-
tion were mainly caused by a significant increase 
in EPA + DHA. A reduction of saturated fatty acid 
C16 : 0 was unexpected but adds to the positive 
effects obtained by OceanSilver herring oil cap-
sules on the omega-3 index as well as the athero-
genic index.
Discussion
The study demonstrated that the omega-3 in-
dex in the urban population in the Czech Republic 
was relatively low, indicating a high risk for cardio-
vascular disease [24]. However, the average num-
ber was somewhat higher than expected based 
on comparisons with other populations having no 
or low intake of seafood [14–16].
The population reported consisted of 95 sub-
jects (100 subjects minus one drop-out and four 
outliers omitted from analyses), with a normal age 
and BMI distribution having adhered to a  study 
medication of two herring oil capsules daily for 
6 months. The omega-3 index increased signifi-
cantly, bringing the average value from 5.1 to 
10.7%, meaning that most of the participants 
were brought into values defined as optimal re-
garding risk for cardiovascular disease. Sixty per-
cent of the study population reached omega-3 
index values ≥ 8%, indicating “low cardiovascular 
risk”, and 23% reached values between five and 
eight, indicating “intermediate risk”. Therefore, 
as much as 83% of the study population reduced 
their cardiovascular risk significantly by two cap-
sules of the herring oil product. Only 17% could be 
regarded as non-responders, probably indicating 
a need for a higher dose. 
The omega-3 index is a complex parameter due 
to the fact that the actual value is dependent not 
only on the EPA + DHA values, but also on a range 
of saturated, monounsaturated, and poly-unsatu-
rated fatty acids located in the denominator. In re-
sponse to the intervention in the study, the EPA + 
DHA values increased significantly from 0.50 μg/
ml to 1.06 μg/ml, an increase of 112%. High EPA + 
DHA values alone are associated with reduced risk 
of cardiovascular disease [2, 25]. Therefore, the in-
crease is very positive and in itself indicative for 
a preventive effect against cardiovascular disease. 
At the same time, low levels of the saturated fatty 
acid palmitic acid (C16 : 0) would be recognized as 
 Before After
Figure 5. EPA + DHA in red blood cells before and 
after study completion
Mean values ± SEM; significantly different p < 0.01.
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beneficial. But how about oleic acid (C18 : 1 n-9), 
an important constituent of the Mediterranean 
diet, which is located along with saturated fatty 
acids on the denominator side? One would rath-
er locate oleic acid on the beneficial side. These 
problems became even more evident when com-
paring values at inclusion with values at the study 
end, since treatment induced a significant reduc-
tion in palmitic acid located in the denominator of 
the omega-3 index ratio. A parameter where the 
intervention induces factors on the nominator but 
also in the denominator is problematic. Therefore, 
the omega-3 index, being a very valid parameter 
of marine omega-3 fatty acid intake and evalua-
tion of cardiovascular risk, is probably less useful 
in intervention studies with omega-3 products. 
Another ratio separating saturated fatty acids 
from poly- and mono-unsaturated fatty acids is 
the atherogenic index. In the present study, this 
index was reduced by 12.5% in response to the 
intervention. Since the difference was not statisti-
cally significant, it only indicates reduced athero-
genic risk. 
Systemic low-grade inflammation is common 
in the adult population due to metabolic disarray 
connected to obesity or type 2 diabetes mellitus. 
A high intake of saturated fatty acids in combina-
tion with a low intake of seafood and antioxidants 
is blamed for part of the inflammatory situation 
common in our society. Unhealthy dietary hab-
its with low intake of fish, fruit and vegetables is 
linked to a number of degenerative diseases, not 
only cardiovascular disease, but also dementia, 
and age-related macular degeneration. 
Omega-3 capsules often contain fish oil from 
species groups such as sardines or anchovies 
[25]. The present study is possibly the first one 
to demonstrate potentially beneficial changes 
in blood fatty acid concentrations after intake 
of capsules containing oil from Atlantic herring. 
Thus, findings of the study may be used to di-
versify the sources from which omega-3 capsules 
may be manufactured. In addition, it could be pos-
sible to classify these capsules as particularly en-
vironmentally friendly, e.g., by using some kind of 
eco-labelling. Overfishing is otherwise a common 
and global problem while Atlantic herring in the 
North-East Atlantic is currently being fished sus-
tainably [26].
In conclusion, the herring oil capsules used, 
providing a  daily dose of 250 mg of omega-3 
fatty acids as recommended by EU Health Au-
thorities, increased the EPA + DHA concentration 
in red blood cells significantly in a  Czech urban 
population with a high cardiovascular risk profile. 
The omega-3 index in the participants increased 
from suboptimal initial values to indexes consis-
tent with low or intermediate cardiovascular risk 
in 83% of the study population.  The reduction in 
the risk profile was mainly caused by an increase 
in the EPA + DHA concentration and to a  minor 
extent by a reduction of the atherogenic palmitic 
acid. The sum of EPA + DHA seems to be a more 
robust indicator of risk, since the calculation of 
the omega-3 index includes a number of fatty ac-
ids which, like the monounsaturated fatty acids, 
do not represent a negative impact on cardiovas-
cular disease risk. The herring oil capsules provide 
a  safe and effective vehicle for omega-3 supple-
mentation in humans. 
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